跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 90,612 条关于
“IgG4-disease”
全部
90,612
临床试验
67,888
药物
1,474
机构
166
资讯
21,084
3年前
Obexelimab Shows Promise in Treating IgG4-Related Disease
去年
Inebilizumab Shows Promise in Treating IgG4-Related Disease
去年
FDA Approves First Targeted Therapy for IgG4-Related Disease: Amgen's UPLIZNA
去年
IgG4-Related Disease: Clinical Trials Update and Emerging Therapies
去年
Acepodia's ACE1831 Receives FDA IND Clearance for IgG4-Related Disease Trial
去年
Acepodia's ACE1831 Receives FDA IND Clearance for IgG4-Related Disease
去年
Acepodia's ACE1831 Receives FDA IND Clearance for IgG4-Related Disease
9个月前
Zenas BioPharma Reports Positive Phase 3 INDIGO Data for Obexelimab in IgG4-Related Disease
去年
Uplizna Shows Remarkable Efficacy in Reducing Flares and Glucocorticoid Dependence in IgG4-Related Disease
去年
UPLIZNA Becomes First FDA-Approved Treatment for IgG4-Related Disease, Reducing Flare Risk by 87%
第 1 页,共 2109 页
上一页
下一页